Europe’s Cancer Mental Health Guidelines Leave Children, Families and Digital Care Behind

A cancer diagnosis is never only a physical event. Across Europe, roughly one in twenty people will hear the words “you have cancer” at some point in their lives, and the psychological shockwave that follows can be as disabling as the disease itself. Anxiety, depression, emotional distress, fear of recurrence, and a quieter but equally pervasive problem, cognitive impairment, which affects an estimated 30 to 40 percent of cancer patients, all shadow the clinical journey from diagnosis through treatment and into survivorship. Now, a large systematic review published in Supportive Care in Cancer has taken stock of how Europe’s clinical practice guidelines, the documents meant to translate evidence into bedside practice, actually address this psychological and cognitive burden, and the picture it paints is one of real progress shadowed by striking gaps.

The review, conducted by an international team led by researchers at the European Institute of Oncology in Milan and carried out within the EU4Health-funded ALTHEA project, systematically searched PsycINFO, Scopus and Medline for clinical practice guidelines and recommendations on psychological and cognitive assessment and support for cancer patients and their families. The team applied strict inclusion criteria: guidelines had to be applicable at European or national level within EU countries, published in English within the last fifteen years, and explicitly address evidence-based psychological or cognitive care. After screening 3,622 retrieved records and removing more than 1,500 duplicates, the researchers settled on 38 publications, a corpus spanning 2011 to 2025 that includes formal guidelines, position papers, consensus statements and recommendations from bodies such as the European Society for Medical Oncology, national guideline programmes in Germany, the United Kingdom and Italy, and pan-European collaborations.

The temporal pattern alone tells a story. Publications clustered at one to five per year, with distinct peaks in 2021 and 2023, a surge the authors link to broader European policy momentum, most notably Europe’s Beating Cancer Plan, launched in 2021, which explicitly foregrounds quality of life and psychosocial well-being alongside survival. Equally telling is who writes these documents. Every guideline included in the review emerged from a multidisciplinary, multi-institutional process, and their recommendations are addressed to a wide cast of clinical actors: oncologists in 30 of the 38 documents, nurses in 27, allied health professionals in 24, multidisciplinary teams in 21, psychosocial and mental health specialists in 18, and palliative care experts in 15. Roughly a third of the guidelines even speak directly to patients, survivors and caregivers, an acknowledgment that the people living with cancer are themselves stakeholders in how their minds are cared for.

Yet the populations these guidelines imagine remain narrow. Twenty-seven of the 38 documents target adult cancer patients across disease stages, and 23 are explicitly directed at adults, with only nine adopting a genuinely all-ages approach and a mere five addressing children or adolescents. Elderly patients appear in six guidelines, pregnant patients in just two. This is a significant blind spot given that around 400,000 children and adolescents worldwide are diagnosed with cancer each year, and that young patients face distinct psychological challenges, from separation from family during hospitalisation to exposure to invasive procedures and rigid clinical routines. Caregivers and family members fare somewhat better, appearing as a focus in 19 guidelines, but the review’s authors argue that the relational fabric of cancer care is still systematically under-specified in European guidance.

When it comes to what is actually measured, the guidelines converge on a familiar triad. Psychological distress in the broad sense is addressed in 28 documents, while depression and anxiety each appear as priorities in 23. Cognitive impairment, despite affecting up to 40 percent of patients, is explicitly covered in only 14. Less common targets include fear of cancer recurrence in nine guidelines, sleep disorders and insomnia in eight, sexual and intimacy problems in eight, and fatigue in seven, while loneliness, suicidality, spiritual distress and parental grief barely register. The screening instruments recommended are similarly concentrated: the Distress Thermometer, a simple 0-to-10 self-report scale, is endorsed in 16 guidelines, and the Hospital Anxiety and Depression Scale in 13, with the PHQ-9 depression questionnaire and the EORTC QLQ-C30 quality-of-life instrument cited in four each. More than a third of the guidelines, however, name no specific tool at all, relying instead on vague exhortations to assess psychosocial needs through local protocols, and the timing and frequency of screening are rarely defined with any precision.

The intervention landscape is broader but uneven. Psychosocial support and counselling top the list, recommended in 28 guidelines, followed by formal psychological and psychotherapeutic approaches such as cognitive behavioural therapy, mindfulness-based interventions and supportive-expressive therapy in 22. Education and training, including psychoeducation, self-management skills and communication training for both patients and clinicians, also appear in 22 documents. Communication support features in 16 guidelines, palliative and spiritual care in 13, and psychopharmacological treatment in 10, typically as an adjunct to psychological therapy. But the review uncovered a conspicuous absence at the level of technique: although 11 guidelines mention dyadic interventions that involve both patient and partner or caregiver, none references a specific, evidence-based dyadic protocol or provides operational detail, and the nine guidelines touching on parenting support remain almost entirely descriptive, without a single manualised programme or concrete implementation pathway.

Methodologically, the review applied the AGREE II instrument, a 23-item appraisal tool scoring guidelines across six domains from scope and purpose to editorial independence. The results were mixed in an instructive way. Guidelines excelled at stating their objectives and presenting recommendations clearly, with mean scores of 87.4 percent for scope and purpose and 82.0 percent for clarity of presentation. But the domain measuring rigour of development, the systematic identification, appraisal and synthesis of evidence, averaged just 52.7 percent, with some documents scoring as low as 10 percent. Applicability, the domain assessing whether guidelines explain how recommendations can actually be implemented, barriers and resource implications included, fell below 50 percent. This matters because only 14 of the 38 guidelines employed a formal system for grading levels of evidence, drawing on frameworks such as GRADE, the Oxford Centre for Evidence-Based Medicine scheme and the SIGN system, and 16 provided no graded recommendations at all, leaving clinicians to guess at how strongly to trust a given advice.

These methodological soft spots intersect with a harder structural reality. Only 37 percent of European countries cover the expenses of screening and assessing psychological distress in cancer patients, and studies of psycho-oncological societies have found that restrictive policies in Southern and Eastern Europe widen the resource gap with Northern countries. The review also notes that the United States has developed more specific and detailed psycho-oncological guidelines than Europe, with more explicit protocols and structured implementation procedures. Meanwhile, healthcare providers themselves are often insufficiently familiar with the latest guidelines or lack the training to implement evidence-based psycho-oncology practices, meaning that even well-crafted documents can stall at the point of care. The review’s authors argue that clearer delineation of which professional groups can deliver which interventions, from nurses offering supportive measures to clinical psychologists delivering formal psychotherapy, would make the guidance far more actionable.

Perhaps the most forward-looking gap concerns digital care. Despite the rapid growth of telehealth, mobile mental health applications and hybrid care models, particularly since the COVID-19 pandemic, the European guidelines offer only modest guidance on remote psychological interventions. The authors argue this is an urgent omission, since digital tools could reduce access barriers, engage patients who cannot easily travel, and scale interventions to remote and under-resourced regions, precisely the settings where psycho-oncological services are scarcest. It is a gap the ALTHEA project itself aims to help close, developing a digital platform for psychological and cognitive screening and support for cancer patients, survivors and their caregivers across Europe.

The overall verdict of the review is double-edged. Psycho-oncology has undeniably moved from the margins of cancer care toward its centre in Europe, with a growing, multidisciplinary guideline ecosystem that consistently prioritises distress, anxiety and depression and endorses evidence-based therapies and holistic care models. But the documents that should guarantee that every patient, child, elderly survivor and exhausted caregiver receives timely psychological support remain inconsistent in rigour, silent on digital delivery, thin on family-centred protocols, and unevenly implemented across a continent where financial disparities still determine who gets screened and who does not. The authors call for future guidelines tailored to specific cancer types and age groups, standardised grading and reporting frameworks, explicit screening intervals, and genuine involvement of patients and caregivers in guideline development. Without those changes, the promise that mental health care is an integral part of cancer care will remain, for too many European families, a sentence in a guideline rather than a reality in the clinic.

Subject of Research: European clinical practice guidelines for psychological and cognitive assessment and support in cancer care

Article Title: A comprehensive review of European clinical practice guidelines on psychological and cognitive assessment and support for cancer patients and their families

Article References: A comprehensive review of European clinical practice guidelines on psychological and cognitive assessment and support for cancer patients and their families. (n.d.). https://doi.org/10.1007/s00520-026-11071-5

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11071-5

Keywords: psycho-oncology, clinical practice guidelines, cancer, mental health, psychological distress, cognitive impairment, Distress Thermometer, HADS, caregivers, digital health, Europe, systematic review